An Follow-Up Study of Liver Cirrhosis

An Observational Follow-Up Study of Patients Previously Enrolled in ADR-001-01 Study Against Liver Cirrhosis

This is a follow-up study to assess safety and preliminary clinical activity of ADR-001 in patients with liver cirrhosis (Child-Pugh score; Grade B) caused by Hepatitis C or Nonalcoholic Steatohepatitis. Patients who have already participated in the ADR-001-01 study and completed the last evaluation after 24 weeks of administration will be eligible to this study.

Patients registered will continue follow-up observation and evaluate long-term safety and exploratory efficacy.

Inclusion Criteria:

• Liver cirrhosis patients enrolled in ADR-001-01 study and completed the last observation of the study
• Voluntary signed informed consent

Exclusion Criteria:

• Patients evaluated by investigators as inappropriate